{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T07:00:20Z","timestamp":1785308420405,"version":"3.55.0"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T00:00:00Z","timestamp":1612656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000066","name":"U.S. National Institute for Environmental Health Sciences","doi-asserted-by":"publisher","award":["ES011384"],"award-info":[{"award-number":["ES011384"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000182","name":"U.S. Army Medical Research and Materiel Command","doi-asserted-by":"publisher","award":["DAMD17-98-1-8625"],"award-info":[{"award-number":["DAMD17-98-1-8625"]}],"id":[{"id":"10.13039\/100000182","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. National Institute for Neurological and Communicative Disorders and Stroke","doi-asserted-by":"publisher","award":["NS05765"],"award-info":[{"award-number":["NS05765"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,22]]},"DOI":"10.1093\/jnen\/nlab006","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T19:08:33Z","timestamp":1612811313000},"page":"286-288","source":"Crossref","is-referenced-by-count":6,"title":["Cycad Genotoxin Methylazoxymethanol Disrupts the Brain Ubiquitin-Proteasome Pathway, Tau and \u03b1-Synuclein, as Reported in ALS-PDC"],"prefix":"10.1093","volume":"80","author":[{"given":"Glen E","family":"Kisby","sequence":"first","affiliation":[{"name":"Pharmacology, Western University for Health Sciences , Lebanon, Oregon, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason L","family":"Eriksen","sequence":"additional","affiliation":[{"name":"Pharmacology, University of Houston , Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C","family":"Chlebowski","sequence":"additional","affiliation":[{"name":"Pharmacology, Western University for Health Sciences , Lebanon, Oregon, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S","family":"Spencer","sequence":"additional","affiliation":[{"name":"Neurology, School of Medicine and Oregon Institute of Occupational Health Sciences, Oregon Health & Science University , Portland, Oregon, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,2,7]]},"reference":[{"key":"2024032523382631600_nlab006-B1","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/jnen\/nlaa056","article-title":"Expression of mutant ubiquitin and proteostasis impairment in Kii Amyotrophic Lateral Sclerosis\/Parkinsonism-Dementia Complex brains","volume":"79","author":"Verheijen","year":"2020","journal-title":"J Neuropathol Exp Neurol"},{"key":"2024032523382631600_nlab006-B2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/jnen\/nlz110","article-title":"Activation of the unfolded protein response and proteostasis disturbance in parkinsonism-dementia of Guam","volume":"79","author":"Verheijen","year":"2020","journal-title":"J Neuropathol Exp Neurol"},{"key":"2024032523382631600_nlab006-B3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s40478-017-0490-0","article-title":"Deposition of mutant ubiquitin in parkinsonism-dementia complex of Guam","volume":"5","author":"Verheijen","year":"2017","journal-title":"Acta Neuropathol Commun"},{"key":"2024032523382631600_nlab006-B4","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.3390\/ijerph8103889","article-title":"Is neurodegenerative disease a long-latency response to early-life genotoxin exposure?","volume":"8","author":"Kisby","year":"2011","journal-title":"Int J Environ Res Public Health"},{"key":"2024032523382631600_nlab006-B5","doi-asserted-by":"crossref","first-page":"100230","DOI":"10.1016\/j.ensci.2020.100230","article-title":"Kamp\u014d medicine and Muro disease (Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia Complex","volume":"18","author":"Spencer","year":"2020","journal-title":"eNeurologicalSci"},{"key":"2024032523382631600_nlab006-B6","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1212\/WNL.42.7.1336","article-title":"Content of the neurotoxins cycasin (methylazoxymethanol \u03b2-d-glucoside) and BMAA (\u03b2-N-methylamino-l-alanine) in cycad flour prepared by Guam Chamorros","volume":"42","author":"Kisby","year":"1992","journal-title":"Neurology"},{"key":"2024032523382631600_nlab006-B7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/jnnp.61.2.131","article-title":"Neuroepidemiology of amyotrophic lateral sclerosis: Clues to aetiology and pathogenesis","volume":"61","author":"Rom\u00e1n","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2024032523382631600_nlab006-B8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/mutage\/17.5.439","article-title":"Comparative potencies of induction of point mutations and genetic duplications by the methylating agents methylazoxymethanol and dimethyl sulfate in bacteria","author":"Hoffman","year":"2002","journal-title":"Mutagenesis"},{"key":"2024032523382631600_nlab006-B9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/exnr.1998.6962","article-title":"The Guam cycad toxin methylazoxymethanol damages neuronal DNA and modulates tau mRNA expression and excitotoxicity","volume":"155","author":"Esclaire","year":"1999","journal-title":"Exp Neurol"},{"key":"2024032523382631600_nlab006-B10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/EB.S260823","article-title":"Etiology of retinal and cerebellar pathology in Western Pacific Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia Complex","volume":"12","author":"Spencer","year":"2020","journal-title":"Eye Brain"},{"key":"2024032523382631600_nlab006-B11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nbd.2004.11.014","article-title":"Molecular networks perturbed in a developmental animal model of brain injury","volume":"19","author":"Kisby","year":"2005","journal-title":"Neurobiol Dis"},{"key":"2024032523382631600_nlab006-B12","author":"Kisby","year":"2008"},{"key":"2024032523382631600_nlab006-B13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/bpa.12500","article-title":"Unusual tau pathology of the cerebellum in patients with amyotrophic lateral sclerosis\/parkinsonism-dementia complex from the Kii Peninsula, Japan","volume":"28","author":"Morimoto","year":"2018","journal-title":"Brain Pathol"},{"key":"2024032523382631600_nlab006-B14","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1021\/pr060126g","article-title":"Proteomic analysis of the genotoxicant methylazoxymethanol (MAM)-induced changes in the developing cerebellum","volume":"5","author":"Kisby","year":"2006","journal-title":"J Proteome Res"},{"key":"2024032523382631600_nlab006-B15","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2353\/ajpath.2007.070015","article-title":"Quantitative proteomics identifies surfactant-resistant \u03b1-synuclein in cerebral cortex of Parkinsonism-Dementia Complex of Guam but not Alzheimer\u2019s Disease or progressive supranuclear palsy","volume":"171","author":"Yang","year":"2007","journal-title":"Am J Pathol"},{"key":"2024032523382631600_nlab006-B16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.molmed.2017.11.006","article-title":"Targeting the 26S proteasome to protect against proteotoxic diseases","volume":"24","author":"Myeku","year":"2018","journal-title":"Trends Mol Med"}],"container-title":["Journal of Neuropathology & Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/80\/3\/286\/42263369\/nlab006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/80\/3\/286\/42263369\/nlab006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:02:02Z","timestamp":1711411322000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnen\/article\/80\/3\/286\/6130087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,7]]},"references-count":16,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,2,7]]},"published-print":{"date-parts":[[2021,2,22]]}},"URL":"https:\/\/doi.org\/10.1093\/jnen\/nlab006","relation":{},"ISSN":["0022-3069","1554-6578"],"issn-type":[{"value":"0022-3069","type":"print"},{"value":"1554-6578","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3,1]]},"published":{"date-parts":[[2021,2,7]]}}}